SUBSCRIBE
SUBSCRIBE

Nektar Therapeutics

NEWS
The Week In Review: From Optimism To Pessimism In Three Short Weeks
October 19, 2005
 · 
1 min read
Ten Drugs To Watch
October 19, 2005
 · 
3 min read
Bated Breath For Inhaled Insulin
October 19, 2005
 · 
1 min read
Load More
AWARDS
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Business
Nektar Therapeutics Strengthens Board of Directors with Appointment of Diana M. Brainard, M.D.
November 15, 2021
 · 
2 min read
Biotech Bay
Nektar Therapeutics Announces Data Presentations for Its Immuno-Oncology Pipeline at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 12, 2021
 · 
10 min read
Biotech Bay
Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors with Cancer Specialist During 2021 Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
November 9, 2021
 · 
6 min read
Business
Nektar Therapeutics Reports Third Quarter 2021 Financial Results
November 4, 2021
 · 
13 min read
Business
Nektar to Announce Financial Results for the Third Quarter 2021 on Thursday, November 4, 2021, After Close of U.S.-Based Financial Markets
October 26, 2021
 · 
1 min read
Business
Nektar Announces New Clinical Collaboration with Merck KGaA Darmstadt, Germany and Pfizer Inc. to Combine NKTR-255, a Novel Interleukin-15 Agonist, with Avelumab in the JAVELIN Bladder Medley Study
September 21, 2021
 · 
9 min read
Business
Nektar Therapeutics Reports Second Quarter 2021 Financial Results
August 5, 2021
 · 
14 min read
Business
Nektar to Announce Financial Results for the Second Quarter 2021 on Thursday, August 5, 2021, After Close of U.S.-Based Financial Markets
July 27, 2021
 · 
1 min read
Policy
RedHill Biopharma Announces Settlement of Movantik® Patent Litigation with Apotex
July 22, 2021
 · 
6 min read
Business
Nektar Appoints Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice President and Chief Medical Officer
July 19, 2021
 · 
6 min read
Load More